TrialProceedings of the National Academy of Sciences of the United States of America2004

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

Ian D Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.